Baidu
map

精品指南:愚人节不骗你,脓毒症和脓毒性休克指南干货来袭

2017-04-01 MedSci MedSci原创

    严重脓毒症、脓毒性休克相关性脏器功能障碍是引起重症监护病房患者死亡的最常见原因,尽管实施严密的脏器功能监护、早期积极的液体复苏、合理应用抗微生物制剂、有效的脏器功能支持,但严重脓毒症患者的病死率仍居高不下。为帮助临床医生更好处理脓毒症和脓毒性休克病患,梅斯小编整理了英文版、中文版及解读版的脓毒症和脓毒性休克管理指南,供大家参考! 一、2016 拯救脓毒运动:

   
严重脓毒症、脓毒性休克相关性脏器功能障碍是引起重症监护病房患者死亡的最常见原因,尽管实施严密的脏器功能监护、早期积极的液体复苏、合理应用抗微生物制剂、有效的脏器功能支持,但严重脓毒症患者的病死率仍居高不下。为帮助临床医生更好处理脓毒症和脓毒性休克病患,梅斯小编整理了英文版、中文版及解读版的脓毒症和脓毒性休克管理指南,供大家参考!

一、2016 拯救脓毒运动:脓毒症和脓毒性休克的管理国际指南(英文版)
  
脓毒症是由特异表达感染的宿主反应引起的致命性器官功能障碍。脓毒症和脓毒性休克是主要医疗问题。每年在世界各地影像了数以百万的人群。本文为临床医生管理成人脓毒症和脓毒性休克成人患者提供临床指导。 二、2016 拯救脓毒运动:脓毒症和脓毒性休克的管理国际指南(中文版)

美国重症医学会联合欧洲危重病医学会发布了2016版脓毒症和脓毒症休克国际处理指南,凤凰翻译组对指南的主要内容进行了翻译。 三、拯救脓毒症运动:脓毒症与感染性休克治疗国际指南(2016)的进展与评论

脓毒症目前仍然是临床面临的难题,促使临床医生对其诊疗方案进行不断探索。近期,美国重症医学会与欧洲重症医学会对脓毒症与感染性休克治疗国际指南做了进一步更新,将一定程度上改变临床医师对脓毒症的诊疗行为。正确理解新版指南是进行脓毒症有效治疗的关键。 精品课程:王国印:氧代谢与脓毒症(上)

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1687083, encodeId=606b168e08385, content=<a href='/topic/show?id=b038851865c' target=_blank style='color:#2F92EE;'>#脓毒性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85186, encryptionId=b038851865c, topicName=脓毒性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9828318255, createdName=1249857fm41暂无昵称, createdTime=Wed Nov 01 06:03:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290268, encodeId=cf8b12902685d, content=<a href='/topic/show?id=7d058518e56' target=_blank style='color:#2F92EE;'>#脓毒性休克#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85187, encryptionId=7d058518e56, topicName=脓毒性休克)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Mon Apr 03 02:03:00 CST 2017, time=2017-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184382, encodeId=be9f1843821d, content=涨知识,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Apr 01 23:20:56 CST 2017, time=2017-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184297, encodeId=a8b018429e5e, content=谢谢指南有用的, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Apr 01 12:05:15 CST 2017, time=2017-04-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1687083, encodeId=606b168e08385, content=<a href='/topic/show?id=b038851865c' target=_blank style='color:#2F92EE;'>#脓毒性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85186, encryptionId=b038851865c, topicName=脓毒性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9828318255, createdName=1249857fm41暂无昵称, createdTime=Wed Nov 01 06:03:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290268, encodeId=cf8b12902685d, content=<a href='/topic/show?id=7d058518e56' target=_blank style='color:#2F92EE;'>#脓毒性休克#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85187, encryptionId=7d058518e56, topicName=脓毒性休克)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Mon Apr 03 02:03:00 CST 2017, time=2017-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184382, encodeId=be9f1843821d, content=涨知识,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Apr 01 23:20:56 CST 2017, time=2017-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184297, encodeId=a8b018429e5e, content=谢谢指南有用的, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Apr 01 12:05:15 CST 2017, time=2017-04-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1687083, encodeId=606b168e08385, content=<a href='/topic/show?id=b038851865c' target=_blank style='color:#2F92EE;'>#脓毒性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85186, encryptionId=b038851865c, topicName=脓毒性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9828318255, createdName=1249857fm41暂无昵称, createdTime=Wed Nov 01 06:03:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290268, encodeId=cf8b12902685d, content=<a href='/topic/show?id=7d058518e56' target=_blank style='color:#2F92EE;'>#脓毒性休克#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85187, encryptionId=7d058518e56, topicName=脓毒性休克)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Mon Apr 03 02:03:00 CST 2017, time=2017-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184382, encodeId=be9f1843821d, content=涨知识,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Apr 01 23:20:56 CST 2017, time=2017-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184297, encodeId=a8b018429e5e, content=谢谢指南有用的, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Apr 01 12:05:15 CST 2017, time=2017-04-01, status=1, ipAttribution=)]
    2017-04-01 1ddf0692m34(暂无匿称)

    涨知识,学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1687083, encodeId=606b168e08385, content=<a href='/topic/show?id=b038851865c' target=_blank style='color:#2F92EE;'>#脓毒性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85186, encryptionId=b038851865c, topicName=脓毒性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9828318255, createdName=1249857fm41暂无昵称, createdTime=Wed Nov 01 06:03:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290268, encodeId=cf8b12902685d, content=<a href='/topic/show?id=7d058518e56' target=_blank style='color:#2F92EE;'>#脓毒性休克#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85187, encryptionId=7d058518e56, topicName=脓毒性休克)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Mon Apr 03 02:03:00 CST 2017, time=2017-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184382, encodeId=be9f1843821d, content=涨知识,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Apr 01 23:20:56 CST 2017, time=2017-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184297, encodeId=a8b018429e5e, content=谢谢指南有用的, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Apr 01 12:05:15 CST 2017, time=2017-04-01, status=1, ipAttribution=)]
    2017-04-01 flysky120

    谢谢指南有用的

    0

相关资讯

Crit Care Med:急性呼吸窘迫综合征合并脓毒症患者是否应该早期使用激素?

近期,一项发表在杂志Crit Care Med上的研究旨在确定入院前接受口服皮质类固醇与急性呼吸窘迫综合征危重患者脓毒症之间的关联。此项研究是回顾性观察研究。共有1,080例重症脓毒症患者参与研究。ICU入院后96小时内,未调整的急性呼吸窘迫综合征发生率在接受口服糖皮质激素的患者中为35%,而未接受口服糖皮质激素的患者中发生率为42%(p = 0.107)。在控制预先指定的混杂因素的多变量分析中,

Crit Care Med:降钙素原水平与脓毒症患者的死亡率密切相关!

近期,一项发表在杂志Crit Care Med上的研究前瞻性地评估了败血症患者中,降钙素原水平在基线和第4天之间未能降低超过80%与患者28天全因死亡率增加的相关性。此项研究为盲法前瞻性多中心观察性临床试验,遵循食品和药物管理局批准的协议。此项研究在美国的十三个急诊科和ICU中进行。受试人群为符合严重脓毒症或败血性休克标准的患者,这些患者从急诊部,其他病房或直接从医院获准进入ICU。在最初5天中每

Crit Care Med:脓毒症患者解热治疗对死亡率有啥影响?

由此可见,解热药并不能显著改善成年脓毒症患者28天/住院死亡率。

Am J Resp Crit Care:脓毒症早期抗生素治疗时机与住院死亡率有啥关系?

在一个大型的、当代多中心的急诊科脓毒症患者的样本中,抗生素使用延误与住院死亡率的几率增加有关,即使在所有6小时内接受抗生素治疗的患者中。在感染性休克患者中脓毒症严重程度增加和死亡率增加的可能性最大。

Crit Care Med:脓毒症患者记忆B细胞会出现活化相关的加速凋亡!

由此可见,耗竭记忆B细胞有助于脓毒症引起的免疫抑制。针对逆转这一免疫记忆耗竭的治疗值得进一步调查研究。

汇总:近期脓毒症重大研究成果进展

脓毒症是一种危及生命的疾病,是由感染引起的全身炎症反应综合征,机体的炎症反应伤及自身组织和器官。每年美国有超过230000名患者出现脓毒症,且他们最初是在在急诊科接受护理。尽管医护人员拼尽全力,仍有1/5的患者最后不幸死亡。医生必须能够快速诊断患者是否出现脓毒症,并及时治疗,不得延迟。他们必须精通不同的治疗方法,并且在不同的感染性休克类型下,患者很可能会得到最好的治疗并存活下来。事实证明,脓毒

Baidu
map
Baidu
map
Baidu
map